Asterias Biotherapeutics, Inc. Accumulated Other Comprehensive Income
Asterias Biotherapeutics, Inc. had Accumulated Other Comprehensive Income of $0 as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2018-11-09
- 2018-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2018-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2018-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $0.00.
- 2017-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$6.50M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$6.50M 10-Q · filed 2018-11-09 | |
| 2017-09-30 | -$3.85M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | -$3.21M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$1.91M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | -$1.08M 10-K · filed 2018-03-15 | |
| 2016-09-30 | -$348.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$5.06M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$4.40M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $434.00K 10-K · filed 2017-03-28 | |
| 2015-09-30 | -$2.33M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | -$752.00K 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $2.60M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | -$503.00K 10-K · filed 2016-03-29 | -$502.66K 10-K · filed 2015-03-11 |
| 2014-09-30 | -$3.04M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | -$3.39M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | -$5.70M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | -$2.93M 10-K · filed 2015-03-11 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-17 |